LymphedemaV1, Main, Exploration, bibRecord, 006450

Staging of cutaneous melanoma

Identifieur interne : 006450 ( Main/Exploration ); précédent : 006449; suivant : 006451

Staging of cutaneous melanoma

Auteurs : P. Mohr [Allemagne] ; A. M. M. Eggermont [Pays-Bas] ; A. Hauschild [Allemagne] ; A. Buzaid [Brésil]

Source :

Annals of Oncology [ 0923-7534 ] ; 2009.

RBID : ISTEX:589851F42F3B662B4BF40B6CE86D13FE01352A8D

Abstract

The American Joint Committee on Cancer (AJCC) staging of cutaneous melanoma is a continuously evolving system. The identification of increasingly more accurate prognostic factors has led to major changes in melanoma staging over the years, and the current system described in this review will likely be modified in the near future. Likewise, application of new imaging techniques has also changed the staging work-up of patients with cutaneous melanoma. Chest and abdominal computed tomography (CT) scanning is most commonly used for evaluation of potential metastatic sites in the lungs, lymph nodes and liver, and is indicated in patients with new symptoms, anaemia, elevated lactate dehydrogenase or a chest X-ray abnormality. CT scans should be restricted to patients with high-risk melanoma (stage IIC, IIIB, IIIC and stage IIIA with a macroscopic sentinel lymph node). Magnetic resonance imaging (MRI) of the brain is a mandatory test in patients with stage IV, optional in stage III and not used in patients with stage I and II disease. Positron emission tomography (PET)/CT is more accurate than CT or MRI alone in the diagnosis of metastases and should complement conventional CT/MRI imaging in the staging work-up of patients who have solitary or oligometastatic disease where surgical resection is most relevant.

Url:

DOI: 10.1093/annonc/mdp256

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Staging of cutaneous melanoma</title>
<author><name sortKey="Mohr, P" sort="Mohr, P" uniqKey="Mohr P" first="P." last="Mohr">P. Mohr</name>
</author>
<author><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A. M. M." last="Eggermont">A. M. M. Eggermont</name>
</author>
<author><name sortKey="Hauschild, A" sort="Hauschild, A" uniqKey="Hauschild A" first="A." last="Hauschild">A. Hauschild</name>
</author>
<author><name sortKey="Buzaid, A" sort="Buzaid, A" uniqKey="Buzaid A" first="A." last="Buzaid">A. Buzaid</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:589851F42F3B662B4BF40B6CE86D13FE01352A8D</idno>
<date when="2009" year="2009">2009</date>
<idno type="doi">10.1093/annonc/mdp256</idno>
<idno type="url">https://api.istex.fr/document/589851F42F3B662B4BF40B6CE86D13FE01352A8D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002893</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002893</idno>
<idno type="wicri:Area/Istex/Curation">002893</idno>
<idno type="wicri:Area/Istex/Checkpoint">000B90</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000B90</idno>
<idno type="wicri:doubleKey">0923-7534:2009:Mohr P:staging:of:cutaneous</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712594</idno>
<idno type="RBID">PMC:2712594</idno>
<idno type="wicri:Area/Pmc/Corpus">003B09</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003B09</idno>
<idno type="wicri:Area/Pmc/Curation">003B08</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003B08</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003583</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003583</idno>
<idno type="wicri:Area/Ncbi/Merge">003517</idno>
<idno type="wicri:Area/Ncbi/Curation">003517</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003517</idno>
<idno type="wicri:doubleKey">0923-7534:2009:Mohr P:staging:of:cutaneous</idno>
<idno type="wicri:Area/Main/Merge">006528</idno>
<idno type="wicri:Area/Main/Curation">006450</idno>
<idno type="wicri:Area/Main/Exploration">006450</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Staging of cutaneous melanoma</title>
<author><name sortKey="Mohr, P" sort="Mohr, P" uniqKey="Mohr P" first="P." last="Mohr">P. Mohr</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Elbekliniken, Buxtehude</wicri:regionArea>
<wicri:noRegion>Buxtehude</wicri:noRegion>
<wicri:noRegion>Buxtehude</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A. M. M." last="Eggermont">A. M. M. Eggermont</name>
<affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Surgical Oncology, Erasmus University Medical CenterDaniel den Hoed Cancer Center, Rotterdam</wicri:regionArea>
<placeName><settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hauschild, A" sort="Hauschild, A" uniqKey="Hauschild A" first="A." last="Hauschild">A. Hauschild</name>
<affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Dermatology, University of Kiel, Kiel</wicri:regionArea>
<placeName><region type="land" nuts="2">Schleswig-Holstein</region>
<settlement type="city">Kiel</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Buzaid, A" sort="Buzaid, A" uniqKey="Buzaid A" first="A." last="Buzaid">A. Buzaid</name>
<affiliation wicri:level="3"><country xml:lang="fr">Brésil</country>
<wicri:regionArea>Centro de Oncologia do Hospital Srio-Libans, Sao Paulo</wicri:regionArea>
<placeName><settlement type="city">São Paulo</settlement>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of Oncology</title>
<idno type="ISSN">0923-7534</idno>
<idno type="eISSN">1569-8041</idno>
<imprint><publisher>Oxford University Press</publisher>
<date type="published" when="2009">2009</date>
<biblScope unit="volume">20</biblScope>
<biblScope unit="supplement">suppl_6</biblScope>
<biblScope unit="page" from="14">vi14</biblScope>
<biblScope unit="page" to="21">vi21</biblScope>
</imprint>
<idno type="ISSN">0923-7534</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0923-7534</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">The American Joint Committee on Cancer (AJCC) staging of cutaneous melanoma is a continuously evolving system. The identification of increasingly more accurate prognostic factors has led to major changes in melanoma staging over the years, and the current system described in this review will likely be modified in the near future. Likewise, application of new imaging techniques has also changed the staging work-up of patients with cutaneous melanoma. Chest and abdominal computed tomography (CT) scanning is most commonly used for evaluation of potential metastatic sites in the lungs, lymph nodes and liver, and is indicated in patients with new symptoms, anaemia, elevated lactate dehydrogenase or a chest X-ray abnormality. CT scans should be restricted to patients with high-risk melanoma (stage IIC, IIIB, IIIC and stage IIIA with a macroscopic sentinel lymph node). Magnetic resonance imaging (MRI) of the brain is a mandatory test in patients with stage IV, optional in stage III and not used in patients with stage I and II disease. Positron emission tomography (PET)/CT is more accurate than CT or MRI alone in the diagnosis of metastases and should complement conventional CT/MRI imaging in the staging work-up of patients who have solitary or oligometastatic disease where surgical resection is most relevant.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Brésil</li>
<li>Pays-Bas</li>
</country>
<region><li>Hollande-Méridionale</li>
<li>Schleswig-Holstein</li>
<li>État de São Paulo</li>
</region>
<settlement><li>Kiel</li>
<li>Rotterdam</li>
<li>São Paulo</li>
</settlement>
</list>
<tree><country name="Allemagne"><noRegion><name sortKey="Mohr, P" sort="Mohr, P" uniqKey="Mohr P" first="P." last="Mohr">P. Mohr</name>
</noRegion>
<name sortKey="Hauschild, A" sort="Hauschild, A" uniqKey="Hauschild A" first="A." last="Hauschild">A. Hauschild</name>
</country>
<country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Eggermont, A M M" sort="Eggermont, A M M" uniqKey="Eggermont A" first="A. M. M." last="Eggermont">A. M. M. Eggermont</name>
</region>
</country>
<country name="Brésil"><region name="État de São Paulo"><name sortKey="Buzaid, A" sort="Buzaid, A" uniqKey="Buzaid A" first="A." last="Buzaid">A. Buzaid</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006450 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006450 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:589851F42F3B662B4BF40B6CE86D13FE01352A8D
   |texte=   Staging of cutaneous melanoma
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Staging of cutaneous melanoma

Staging of cutaneous melanoma

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.